Neurophysiology of the neuromuscular junction: Overview

Annals of the New York Academy of Sciences

Volumn 998, Issue , 2003, Pages 1-10

  Ruff, Robert L ^a,b  

^a LOUIS STOKES CLEVELAND VA MEDICAL CENTER   (United States)

^b CASE WESTERN RESERVE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Acetylcholine esterase; Contractility; Neuromuscular junction; Neuromuscular transmission; Quantal transmitter release; Safety factor; Skeletal muscle; Sodium channels; Transmitter release

Indexed keywords

ACETYLCHOLINE; CHOLINERGIC RECEPTOR; SODIUM CHANNEL;

ACETYLCHOLINE RELEASE; BINDING AFFINITY; CONFERENCE PAPER; DEPOLARIZATION; DIFFUSION COEFFICIENT; HUMAN; MOLECULAR BIOLOGY; MOTOR NERVE; MUSCLE ACTION POTENTIAL; MUSCLE CELL; MUSCLE CONTRACTION; MUSCLE EXCITATION; MUSCLE INNERVATION; MUSCLE STRETCHING; NERVE CONDUCTION; NERVE ENDING; NEUROMUSCULAR SYNAPSE; NEUROMUSCULAR TRANSMISSION; NEUROPHYSIOLOGY; POSTSYNAPTIC MEMBRANE; PROTEIN BINDING; PROTEIN PROTEIN INTERACTION; STRUCTURE ANALYSIS; SYNAPSE; SYNAPSE VESICLE; TRANSPORT KINETICS;

EID: 0141859737     PISSN: 00778923     EISSN: None     Source Type: Book Series    
DOI: 10.1196/annals.1254.002     Document Type: Conference Paper

References (88)

1. BURKE, R.E. 2001. The structure and function of motor units. In Disorders of Voluntary Muscle, pp. 3-25. Cambridge Univ. Press. Cambridge.
2. RUFF, R.L. 1986. Ionic channels: II. Voltage- and agonist-gated and agonist-modified channel properties and structure. Muscle Nerve 9: 767-786.
3. SALPETER, M.M. 1987. The Vertebrate Neuromuscular Junction. Alan R. Liss. New York.
4. RUFF, R.L. 1986. Ionic channels: I. The biophysical basis for ion passage and channel gating. Muscle Nerve 9: 675-699.
5. BLACK, J.A., J.D. KOCSIS & S.G. WAXMAN. 1990. Ion channel organization of the myelinated fiber. Trends Neurosci. 13: 48-54.
6. REID, G. et al. 1999. Human axons contain at least five types of voltage-dependent potassium channel. J. Physiol. 518: 681-696.
7. + channels of peripheral nerves. Ann. Neurol. 38: 714-722.
8. NEWSOM-DAVIS, J. et al. 2003. Autoimmune disorders of neuronal potassium channels. This volume.
9. NAGADO, T. et al. 1999. Potassium current suppression in patients with peripheral nerve hyperexcitability. Brain 122: 2057-2066.
10. KATZ, B. 1966. Nerve Muscle and Synapse. McGraw-Hill. New York.
11. AUGUSTINE, G.J., E.M. ADLER & M.P. CHARLTON. 1991. The calcium signal for transmitter secretion from presynaptic nerve terminals. Ann. N.Y. Acad. Sci, 635: 365-381.
12. SMITH, S.J. & G.J. AUGUSTINE. 1988. Calcium ions, active zones, and synaptic transmitter release. Trends Neurosci. 10: 458-464.
13. PROTTI, D.A. et al. 1993. Mammalian neuromuscular transmission blocked by funnel web toxin. Ann. N.Y. Acad. Sci. 681: 405-407.
14. CATTERALL, W.A. et al. 1993. Molecular properties of calcium channels in skeletal muscle and neurons. Ann. N.Y. Acad. Sci. 681: 342-355.
15. STANLEY, E.F. 1993. Presynaptic calcium channels and the transmitter release mechanism. Ann. N.Y. Acad. Sci. 681: 368-372.
16. WRAY, D. & V. PORTER. 1993. Calcium channel types at the neuromuscular junction. Ann. N.Y. Acad. Sci. 681: 356-367.
17. 2+ channels and synaptic transmission at the adult, neonatal, and P/Q-type deficient neuromuscular junction. This volume.
18. ENGEL, A.G. 1991. Review of evidence for loss of motor nerve terminal calcium channels in Lambert-Eaton myasthenic syndrome. Ann. N.Y. Acad. Sci. 635: 246-258.
19. PUMPLIN, D.W., T.S. REESE & R. LLINAS. 1981. Are the presynaptic membrane particles calcium channels? Proc. Natl. Acad. Sci. USA 78: 7210-7213.
20. LINDGREN, C.A. & J.W. MOORE. 1991. Calcium current in motor nerve endings of the lizard. Ann. N.Y. Acad. Sci. 635: 58-69.
21. STANLEY, E.F. & C. COX. 1991. Calcium channels in the presynaptic nerve terminal of the chick ciliary ganglion giant synapse. Ann. N.Y. Acad. Sci. 635: 70-79.
22. LEYS, K. et al. 1991. Calcium channel autoantibodies in the Lambert-Eaton myasthenic syndrome. Ann. Neurol. 29: 307-414.
23. LAMBERT, E.H., L.M. EATON & E.D. ROOKE. 1956. Defect of neuromuscular transmission associated with malignant neoplasm. Am. J. Physiol. 187: 612-613.
24. MOTOMURA, M. et al. 1995. An improved diagnostic assay for Lambert-Eaton myasthenic syndrome. J. Neurol. Neurosurg. Psychiatr. 58: 85-87.
25. NAGEL, A. et al. 1988. Lambert-Eaton syndrome IgG depletes presynaptic membrane active zone particles by antigenic modulation. Ann. Neurol. 24: 552-558.
26. LANG, B. et al. 1993. Autoantibody specificities in Lambert-Eaton myasthenic syndrome. Ann. N.Y. Acad. Sci. 681: 382-391.
27. VIGLIONE, M.P., J.K.W. BLANDINO & Y.I. KIM. 1993. Effects of Lambert-Eaton syndrome serum and IgG on calcium and sodium currents in small-cell lung cancer cells. Ann. N.Y. Acad. Sci. 681: 418-421.
28. 2+ channel complexes. Ann. N.Y. Acad. Sci. 681: 408-411.
29. MASELLI, R.A. 2003. Effect of inherited abnormalities of calcium regulation on human neuromuscular transmission. This volume.
30. MCEVOY, K.M. et al. 1989. 3,4-Diaminopyridine in the treatment of Lambert-Eaton myasthenic syndrome. N. Engl. J. Med. 321: 1567-1571.
31. SANDERS, D.B. 2003. Lambert-Eaton myasthenic syndrome: diagnosis and treatment. This volume.
32. NILES, W.D. & F.S. COHEN. 1991. Video-microscopy studies of vesicle-planar membrane adhesion and fusion. Ann. N.Y. Acad. Sci. 635: 273-306.
33. EHRENSTEIN, G. et al. 1991. Evidence of a model of exocytosis that involves calcium-activated channels. Ann. N.Y. Acad. Sci. 635: 297-306.
34. VINCENT, A. 2001. The neuromuscular junction and neuromuscular transmission. In Disorders of Voluntary Muscle, pp, 142-167. Cambridge Univ. Press. Cambridge.
35. PERIN, M.S. et al. 1990. Phospholipid binding by a synaptic vesicle protein homologous to the regulatory region of protein kinase C. Nature 345: 260-263.
36. PERIN, M.S. et al. 1991. Domain structure of synaptotagmin (p65). J. Biol. Chem. 266: 623-629.
37. ZIMMERBERG, J., M. CURRAN & F.S. COHEN. 1991. A lipid/protein complex hypothesis for exocytotic fusion pore formation. Ann. N.Y. Acad. Sci. 681: 307-317.
38. CREMONA, O. et al. 2003. Protein ubiquitylation and synaptic function. This volume.
39. JAHN, R. 2002. Presynaptic vesicle docking and fusion. This conference.
40. MILEDI, R., P.C. MOLENAAR & R.L. POLAK. 1983. Electrophysiological and chemical determination of acetylcholine release at the frog neuromuscular junction. J. Physiol. (Lond.) 334: 245-254.
41. 2+ in neurotransmitter secretion. Ann. N.Y. Acad. Sci. 635: 90-99.
42. KATZ, B. & R. MILEDI. 1979. Estimates of quantal content during chemical potentiation of transmitter release. Proc. R. Soc. Lond. 205: 369-378.
43. LAND, B.R. et al. 1984. Diffusion and binding constants for acetylcholine derived from the falling phase of miniature endplate currents. Proc. Natl. Acad. Sci. USA 81: 1594-1598.
44. MCMAHAN, U.J., J.R. SANES & L.M. MARSHALL. 1978. Cholinesterase is associated with the basal lamina at the neuromuscular junction. Nature 271: 172-174.
45. KATZ, B. & R. MILEDI. 1973. The binding of acetylcholine to receptors and its removal from the synaptic cleft. J. Physiol. (Lond.) 231: 549-574.
46. SINGH, G. 2002. Postsynaptic toxins of the neuromuscular junction: organophosphates. This conference.
47. LAND, B.R., E.E SALPETER & M.M. SALPETER. 1981. Kinetic parameters for acetylcholine interaction in intact neuromuscular junction. Proc. Natl. Acad. Sci. USA 78: 7200-7204.
48. COLQUHOUN, D. & B. SAKMANN. 1985. Fast events in single-channel currents activated by acetylcholine and its analogues at the frog muscle end-plate. J. Physiol. (Lond.) 369: 501-557.
49. ENGEL, A.G. et al. 2003. Congenital myasthenic syndromes: multiple molecular targets at the neuromuscular junction. This volume.
50. HOLLAND, P.C. & S. CARBONETTO. 2001. The extracellular matrix of skeletal muscle. In Disorders of Voluntary Muscle, pp. 103-121. Cambridge Univ. Press. Cambridge.
51. GAUTAM, M., P.G. NOAKES & L. MOSCOSO. 1996. Defective neuromuscular synaptogenesis in agrin-deficient mutant mice. Cell 85: 525-535.
52. GAUTAM, M., P.G. NOAKES & J. MUDD. 1995. Failure of postsynaptic specialization at neuromuscular junctions of rapsyn-deficient mice. Nature 377: 232-236.
53. WANAMAKER, C.P. et al. 2003. Regulation of nicotinic acetylcholine receptor assembly. This volume.
54. SMIT, A.B. et al. 2001. A glia-derived acetylcholine-binding protein that modulates synaptic transmission. Nature 411: 261-267.
55. + channels and ankyrin in neuromuscular junctions is complementary to that of acetylcholine receptors and the 43 kD protein. Neuron 3: 163-175.
56. SANES, J.R. et al. 1991. Selective expression of an acetylcholine receptor-lacZ transgene in synaptic nuclei of adult muscle fibers. Development 113: 1181-1191.
57. MARTINOU, J.C. et al. 1991. Acetylcholine receptor-inducing activity stimulates expression of the epsilon-subunit gene of the muscle acetylcholine receptor. Proc. Natl. Acad. Sci. USA 88: 7669-7673.
58. MERLIE, J.P. & J.R. SANES. 1985. Concentration of acetylcholine receptor mRNA in synaptic regions of adult muscle fibers. Nature 317: 66-68.
59. BRENMAN, J.E. et al. 1996. Interaction of nitric oxide synthase with the postsynaptic protein PSD-95 and α1-synthophin mediated by PDZ domains. Cell 84: 757-767.
60. KUSNER, L.L. & H.J. KAMINSKI. 1996. Nitric oxide synthase is concentrated at the skeletal muscle endplate. Brain Res. 730: 238-242.
61. SMIT, A.B. et al. 2003. Structure and function of AChBP, homologue of the ligand-binding domain of the nicotinic acetylcholine receptor. This volume.
62. FAIRCLOUGH, R.H. et al. 2003. Agonist-induced transitions of the acetylcholine receptor. This volume.
63. SINE, S.M. et al. 2003. Mechanistic diversity underlying fast channel congenital myasthenic syndromes. This volume.
64. KUFFLER, S.W. & D. YOSHIKAMI. 1975. The distribution of acetylcholine sensitivity at the post-synaptic membrane of vertebrate skeletal twitch muscles: iontophoretic mapping in the micron range. J. Physiol. (Lond.) 244: 703-730.
65. SALPETER, M.M. & R.H. LORING. 1985. Nicotinic acetylcholine receptors in vertebrate muscle: properties, distribution, and neural control. Prog. Neurobiol. 25: 297-325.
66. KAO, I. & D. DRACHMAN. 1977. Myasthenic immunoglobulin accelerates acetylcholine receptor degradation. Science 196: 526-528.
67. MERLIE, J.P., S. HEINEMANN & J.M. LINDSTROM. 1979. Acetylcholine receptor degradation in adult rat diaphragms in organ culture and the effect of anti-acetylcholine receptor antibodies. J. Biol. Chem. 254: 6320-6327.
68. LINDSTROM, J. 2003. Nicotinic acetylcholine receptors of muscles and nerves: comparison of their structures, functional roles, and vulnerability to pathology. This volume.
69. HAIMOVICH, B. et al. 1987. Localization of sodium channel subtypes in rat skeletal muscle using channel-specific monoclonal antibodies. J. Neurosci. 7: 2957-2966.
70. ROBERTS, W.M. 1987. Sodium channels near end-plates and nuclei of snake skeletal muscle. J. Physiol. (Lond.) 388: 213-232.
71. RUFF, R.L. 1992. Na current density at and away from end plates on rat fast- and slow-twitch skeletal muscle fibers. Am. J. Physiol. 262(Cell Physiol. 31): C229-C234.
72. + current densities and voltage dependence in human intercostal muscle fibres. J. Physiol. (Lond.) 458: 85-97.
73. + currents near and away from endplates on human fast and slow twitch muscle fibers. Muscle Nerve 16: 922-929.
74. + currents from type IIa and IIb human intercostal muscle fibers. Am. J. Physiol. 265(Cell Physiol. 34): C171-C177.
75. CALDWELL, J.H., D.T. CAMPBELL & K.G. BEAM. 1986. Sodium channel distribution in vertebrate skeletal muscle. J. Gen. Physiol. 87: 907-932.
76. MILTON, R.L., M.T. LUPA & J.H. CALDWELL. 1992. Fast and slow twitch skeletal muscle fibres differ in their distributions of Na channels near the endplate. Neurosci. Lett. 135: 41-44.
77. RUFF, R.L. & V.A. LENNON. 1998. Endplate voltage-gated sodium channels are lost in clinical and experimental myasthenia gravis. Ann. Neurol. 43: 370-379.
78. VINCENT, A. et al. 2003. Antibodies in myasthenia gravis and related disorders. This volume.
79. BANKER, B.Q., S.S. KELLY & N. ROBBINS. 1983. Neuromuscular transmission and correlative morphology in young and old mice. J. Physiol. (Lond.) 339: 355-375.
80. GERTLER, R.A. & N. ROBBINS. 1978. Differences in neuromuscular transmission in red and white muscles. Brain Res. 142: 255-284.
81. TONGE, D.A. 1974. Chronic effects of botulinum toxin on neuromuscular transmission and sensitivity to acetylcholine in slow and fast skeletal muscle of the mouse. J. Physiol. (Lond.) 241: 127-139.
82. STERZ, R., M. PAGALA & K. PEPER. 1983. Postjunctional characteristics of the endplates in mammalian fast and slow muscles. Pflüg. Arch. 398: 48-54.
83. LASZEWSKI, B. & R.L. RUFF. 1985. The effects of glucocorticoid treatment on excitation-contraction coupling. Am. J. Physiol. 248(Endocrinol. Metab. 11): E363-E369.
84. HENNIG, R. & T. LØMO. 1985. Firing patterns of motor units in normal rats. Nature 314: 164-166.
85. KELLY, S.S. & N. ROBBINS. 1986. Sustained transmitter output by increased transmitter turnover in limb muscles of old mice. J. Neurosci. 6: 2900-2907.
86. LEV-TOV, A. 1987. Junctional transmission in fast- and slow-twitch mammalian muscle units. J. Neurophysiol. 57: 660-671.
87. LEV-TOV, A. & R. FISHMAN. 1986. The modulation of transmitter release in motor nerve endings varies with the type of muscle fiber innervated. Brain Res. 363: 379-382.
88. + current amplitude and excitability near and far from the end-plate. Muscle Nerve 19: 1084-1092.